Literature DB >> 8943684

Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704.

J T Price1, H M Wilson, N E Haites.   

Abstract

Metastasis is a multistep process that involves alterations in a tumour cell's invasion, motility and adhesive capabilities. This study examined the effect of EGF on the in vitro invasion, motility and adhesion of the primary renal adenocarcinoma cell line, A704. Stimulation of the tumour cells by EGF (40 ng/ml) for a period of 24 h increased the in vitro invasion (P = 0.040) and motility (P = 0.039). Cell adhesion was examined on fibronectin, laminin, collagen IV and a 1:1:1 mix of the three extracellular matrix components. After EGF (40 ng/ml) stimulation, adhesion was significantly decreased on fibronectin (P = 0.022) and collagen type IV (P = 0.026), but increased on the 1:1:1 mix of extracellular matrix components (P = 0.022). The 92 kDa matrix metalloproteinase (MMP-9) present in the cell-conditioned medium was also increased after a 24 h stimulation with EGF (40 ng/ml) when measured. Hence, EGF can modulate the in vitro invasion, motility, adhesiveness and matrix metalloproteinase production in the A704 cell line, and subsequently may have a role in the metastatic potential of some renal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943684     DOI: 10.1016/0959-8049(96)00207-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  23 in total

1.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  [EGFR-expression in pulmonary neuroendocrine cell hyperplasia].

Authors:  C Kuhnen; B U Winter
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

3.  Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.

Authors:  Marie Ogawa; Takashi Kojima; Masayuki Someya; Kazuaki Nomura; Akira Takasawa; Masaki Murata; Satoshi Tanaka; Tsuyoshi Saito; Norimasa Sawada
Journal:  Histochem Cell Biol       Date:  2012-04-29       Impact factor: 4.304

4.  Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.

Authors:  Michael W Yeh; Jean-Philippe Rougier; Jin-Woo Park; Quan-Yang Duh; Mariwil Wong; Zena Werb; Orlo H Clark
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

5.  Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer.

Authors:  Andrea Baillo; Craig Giroux; Stephen P Ethier
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

6.  Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis.

Authors:  Danielle Kemmer; Lianne M McHardy; Shawn Hoon; Delphine Rebérioux; Guri Giaever; Corey Nislow; Calvin D Roskelley; Michel Roberge
Journal:  BMC Microbiol       Date:  2009-01-14       Impact factor: 3.605

7.  Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model.

Authors:  Zhihui Wang; Christina M Birch; Jonathan Sagotsky; Thomas S Deisboeck
Journal:  Bioinformatics       Date:  2009-07-04       Impact factor: 6.937

8.  SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion.

Authors:  Arang Kwon; Hye-Lim Lee; Kyung Mi Woo; Hyun-Mo Ryoo; Jeong-Hwa Baek
Journal:  Mol Cells       Date:  2013-11-14       Impact factor: 5.034

9.  c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells.

Authors:  E Gregory MacEwen; Jon Kutzke; Jennifer Carew; Josep Pastor; Julie A Schmidt; Rachel Tsan; Douglas H Thamm; Robert Radinsky
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.

Authors:  Abderrahim El Guerrab; Rabah Zegrour; Carine-Christiane Nemlin; Flavie Vigier; Anne Cayre; Frederique Penault-Llorca; Fabrice Rossignol; Yves-Jean Bignon
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.